Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Development of assays for prognostic factors in oncological endocrinology"'
1
Does Plasminogen Activator Inhibitor-1 (PAI-1) Control Trophoblast Invasion? A Study of Fetal and Maternal Tissue in Intrauterine, Tubal and Molar Pregnancies
Autor: Lone Sunde, Børge Teisner, Charlotte Floridon, Berit Hølund, Ole Haagen Nielsen, Sten Grove Thomsen, F. Sweep
Publikováno v: Placenta, 21, 754-762
Placenta, 21, 8, pp. 754-762
Floridon, C, Nielsen, O, Hølund, B, Sweep, F, Sunde, L, Thomsen, S G & Teisner, B 2000, ' Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies ', Placenta, vol. 21, no. 8, pp. 754-62 . https://doi.org/10.1053/plac.2000.0573
Urokinase plasminogen activator, its receptor and the inhibitor PAI-1 are believed to control proteolysis and remodelling of maternal tissue during trophoblast invasion. This system appears to be strictly regulated in normal intrauterine pregnancies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f533df0947a0adb60bbeb71cd934b156
https://doi.org/10.1053/plac.2000.0573
Zobrazit plný text záznamu
2
Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators
Autor: Jon Askaa, Robert M.W. de Waal, Inge Clemmensen, Johan R. Westphal, Alexander A.M.M. Eggermont, Fred C.J.G. Sweep, Jan H. Verheijen, Anneke Geurts-Moespot, Rianne Van't Hullenaar, Dirk J. Ruiter, Marion M.G. Bussemakers
Publikováno v: International Journal of Cancer, 86, pp. 760-767
International Journal of Cancer, 86(6), 760-767. Wiley-Liss Inc.
International Journal of Cancer, 86, 760-767
Angiostatin is a tumor-derived angiogenesis inhibitor consisting of an internal fragment of plasminogen. Little is known about the production of angiostatin by human tumors. In this study, we examined the in vitro angiostatin-generating capacities of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ede414e53c2d5843f42c0117bb2cd9f
https://doi.org/10.1002/(sici)1097-0215(20000615)86:6<760::aid-ijc2>3.0.co
Zobrazit plný text záznamu
3
Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients
Autor: Maxime P. Look, J.G.M. Klijn, Th.J. Benraad, C.G.J. Sweep, H. A. Peters, N. Grebenschikov, J.A. Foekens, J.H. de Witte, J. J. T. M. Heuvel, Th H van Tienoven, W. L. J. Van Putten
Publikováno v: British Journal of Cancer, 79, 7/8, pp. 1190-1198
British Journal of Cancer
British Journal of Cancer, 79(7/8), 1190-1198. Nature Publishing Group
British Journal of Cancer, 79, 1190-1198
To evaluate the clinical relevance of urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) measured by a recently developed enzyme-linked immunosorbent assay (ELISA), we analysed both components in samples derived from 892 pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f46a1c7e7b0035d9802bd00c7ae37e5
https://doi.org/10.1038/sj.bjc.6690191
Zobrazit plný text záznamu
4
Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin
Autor: Eskens, F.A., Roelofs, E.J.M., Hermus, A.R.M.M., Verhagen, C.A.H.H.V.
Publikováno v: Anticancer Research, 17, pp. 4667-4670
Anticancer Research, 17, 4667-4670
Contains fulltext : 24617___.PDF (Publisher’s version ) (Open Access)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bb47a5dd9c69c827e145a88d44eb4265
https://hdl.handle.net/2066/275104
Zobrazit plný text záznamu
5
Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis
Autor: J. G. M. Klijn, Marcel Smid, Emjj Berns, Maxime P. Look, J.H. de Witte, Th.J. Benraad, Johan Lennerstrand, John A. Foekens
Publikováno v: International Journal of Cancer, 69, pp. 125-130
International Journal of Cancer, 69, 125-130
International Journal of Cancer, 69, 2, pp. 125-130
TP53 accumulation in human primary breast carcinomas was studied by a quantitative luminometric immunoassay (LIA), and TP53 gene alterations, exons 5-8, were examined by single-strand conformation polymorphism (SSCP) analysis. In 48 of 142 breast tum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747f66b5f32fa6be0d4a2a28f541d408
https://doi.org/10.1002/(sici)1097-0215(19960422)69:2<125::aid-ijc10>3.0.co
Zobrazit plný text záznamu
6
Elevated serum endothelin 1 levels in patients with colorectal cancer: relevance for prognosis
Autor: Peeters, C.F.J.M., Thomas, C.M.G., Sweep, C.G.J., Span, P.N., Wobbes, T., Ruers, T.J.M.
Publikováno v: International Journal of Biological Markers, 15, 288-293
International Journal of Biological Markers, 15, pp. 288-293
Item does not contain fulltext
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::47a7fcd2c8831ede66daeb78151fff2c
http://hdl.handle.net/2066/197142
Zobrazit plný text záznamu
7
Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer
Autor: Chris M.G. Thomas, N.A. Mungan, Lambertus A. Kiemeney, J.A. Witjes, J.L.J. Vriesema
Publikováno v: Urology, 56, 5, pp. 787-791
Urology, 56, 787-791
Objectives. To study the diagnostic performance of the Urinary Bladder Cancer (UBC) test in patients with superficial bladder carcinoma. Methods. One hundred one patients in follow-up for superficial bladder cancer (pTa, pT1, carcinoma in situ) were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190b5b1a3e76b92d8a6723cf053c4b71
https://doi.org/10.1016/S0090-4295(00)00798-6
Zobrazit plný text záznamu
8
EORTC Receptor and Biomarker Study Group report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts
Autor: J. R. Westphal, C.G.J. Sweep, Paul N. Span, Nicolai Grebenchtchikov, J. (Anneke) Geurts-Moespot, A. M. J. Lucassen
Publikováno v: International Journal of Biological Markers, 15, 2, pp. 184-191
ResearcherID
International Journal of Biological Markers, 15, 184-191
A four-antibody sandwich enzyme-linked immunosorbent assay (ELISA) for vascular endothelial growth factor (VEGF) for application in blood (serum and plasma) and tumor tissue extracts was set up within the framework of the EORTC Receptor and Biomarker
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e12e3cde914ea24a549715aa7b6e6f
https://repository.ubn.ru.nl/handle/2066/265865
Zobrazit plný text záznamu
10
ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA~PAI-1 and tPA~PAI-1)
Autor: Peter A. Andreasen, Anneke Geurts, N. Grebenschikov, Fred C.G.J. Sweep, J. J. T. M. Heuvel, Hans De Witte, Theo Benraad, Susanne L. Schousboe
Publikováno v: International Journal of Cancer, 81, 598-606
International Journal of Cancer, 81, pp. 598-606
Grebentschikov, N, Sweep, F, Geurts, A, Andreasen, P, de Witte, H, Schousboe, S L, Heuvel, J & Benraad, T 1999, ' ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1) ', International Journal of Cancer, vol. 81, pp. 598-606 .
An ELISA has been developed for the assessment of complexes between the urokinase-type (uPA) and the tissue-type plasminogen (tPA) activators with their inhibitor type-1 (PAI-1) in cell-culture medium and cytosolic extracts of breast tumours. The "4-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cbc4006b80dda764fe350807dfd118
http://hdl.handle.net/2066/224219
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje